F. Gary Toback
Corporate Officer/Principal bei The University of Chicago
Aktive Positionen von F. Gary Toback
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The University of Chicago | Corporate Officer/Principal | 01.01.1985 | - |
Karriereverlauf von F. Gary Toback
Ehemalige bekannte Positionen von F. Gary Toback
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von F. Gary Toback
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| New York University | Doctorate Degree |
| Boston University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 5 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
NephRx Corp.
NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Health Technology |
- Börse
- Insiders
- F. Gary Toback
- Erfahrung
